Neurologic manifestations in inflammatory bowel diseases: Current knowledge and novel insights

Journal of Crohn's and Colitis

Volumn 4, Issue 2, 2010, Pages 115-124

  Zois, Christos D ^a   Katsanos, Konstantinos H ^a   Kosmidou, Maria ^a   Tsianos, Epameinondas V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Co morbidity; Extraintestinal manifestations; Inflammatory bowel diseases; Neurologic symptoms

Indexed keywords

ADALIMUMAB; CASTOR OIL; CERTOLIZUMAB PEGOL; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METRONIDAZOLE; NATALIZUMAB; ONERCEPT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

AXONAL SENSORIMOTOR POLYNEUROPATHY; BRACHIAL PLEXUS NEUROPATHY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NEUROPATHY; CEREBELLUM ATROPHY; CEREBELLUM DISEASE; CEREBRAL BLINDNESS; CEREBROVASCULAR DISEASE; CRANIAL NERVE PARALYSIS; CROHN DISEASE; DEMYELINATING NEUROPATHY; DISEASE ASSOCIATION; DRUG FORMULATION; ENTERITIS; EYE MOVEMENT DISORDER; FOLIC ACID DEFICIENCY; GUILLAIN BARRE SYNDROME; HALLUCINATION; HUMAN; LEUKOENCEPHALOPATHY; MIGRAINE; MONONEUROPATHY MULTIPLEX; MORBIDITY; MOTOR NEUROPATHY; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; MYELORADICULITIS; MYELORADICULOPATHY; MYOPATHY; NEUROLOGIC DISEASE; NEUROMUSCULAR DISEASE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; NUCLEUS PULPOSUS; NYSTAGMUS; OPHTHALMOPLEGIA; OPTIC NERVE DISEASE; ORGANIC BRAIN SYNDROME; PARKINSON DISEASE; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; SEIZURE; SPECTRUM; SPINAL EPIDURAL ABSCESS; SYMPTOMATOLOGY; THROMBOEMBOLISM; THROMBOSIS; TREMOR; ULCERATIVE COLITIS; URINE INCONTINENCE; VESTIBULAR DISORDER; VISUAL DISORDER; VISUAL IMPAIRMENT;

ANTI-INFLAMMATORY AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; CEREBROVASCULAR DISORDERS; COLITIS, ULCERATIVE; CRANIAL NERVE DISEASES; CROHN DISEASE; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; MUSCULAR DISEASES; NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; THROMBOEMBOLISM;

EID: 77952100981     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.10.005     Document Type: Review

References (112)

1. Watts D.A., and Satsangi J. The genetic jigsaw of inflammatory bowel disease. Gut 50 suppl 3 (2002) 31-36 III
2. Elsehety A., and Bertorini T.E. Neurologic and neuropsychiatric complications of Crohn's disease. South Med J 90 (1997) 606-610
3. Greenstein A.J., Janowitz H.D., and Sachar D.B. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 55 (1976) 401-412
4. Rankin G.B., Watts H.D., Melnyk C.S., et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 77 (1979) 914-920
5. Lossos A., River Y., Eliakim A., et al. Neurologic aspects in inflammatory bowel disease. Neurology 45 (1995) 416-421
6. Konturek S.J., Konturek J.W., Pawlik T., et al. Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55 (2004) 137-154
7. Derbyshire S.W.G. A systematic review of neuroimaging data during visceral stimulation. Am J Gastroenterol 98 (2003) 12-20
8. Scheid R., and Teich N. Neurologic manifestations of ulcerative colitis. Eur J Neurol 14 (2007) 483-493
9. Levenstein S., Prantera C., Varvo V., Scribano M.L., Andreoli A., Luzi C., Arcà M., Berto E., Milite G., and Marcheggiano A. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 95 (2000) 1213-1220 10.1111/j.1572-0241.2000.02012.x
10. Meddings J.B., and Swain M.G. Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 119 (2000) 1019-1028 10.1053/gast.2000.18152
11. Hollander D. Inflammatory bowel diseases and brain-gut axis. J Physiol Pharmacol 54 suppl 4 (2003) 183-190
12. Ferrante M., De Hertogh G., Hlavaty T., D'haens G., Penninckx F., D'hoore A., Vermeire S., Rutgeerts P., Geboes K., and Van Assche G. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology 130 (2006) 1595-1606 10.1053/j.gastro.2006.02.025
13. Stahlberg D., Bárány F., Einarsson K., et al. Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole. Scand J Gastroenterol 26 (1991) 219-224
14. Gondim F.A., Brannagan III T.H., Sander H.W., et al. Peripheral neuropathy in patients with inflammatory bowel disease. Brain 128 (2005) 867-879
15. Yesilova Z., Naharci I., Uygun A., et al. Motor axonal polyneuropathy in the course of ulcerative colitis: a case report. Turk J Gastroenterol 17 (2006) 58-61
16. Berden J.H., Hoitsma A.J., Merx J.L., et al. Severe central nervous system toxicity associated with cyclosporine. Lancet 1 (1985) 219-220
17. Porges Y., Blumen S., Fireman Z., et al. Cyclosporine-induced optic neuropathy, ophthalmoplegia and nystagmus in a patient with Crohn's disease. Am J Ophthalmol 126 (1998) 607-609
18. Choudhury N., Neild G.H., Brown Z., et al. Thromboembolic complications in cyclosporine-treated kidney allograft recipients. Lancet 2 (1985) 606-607
19. Thompson C.B., June C.H., Sullivan K.M., et al. Association between cyclosporine neurotoxicity and hypomagnesaemia. Lancet 17 (1984) 1116-1120
20. Rosencrantz R., Moon A., Raynes H., et al. Cyclosporine-induced neurotoxicity during treatment of Crohn's disease: lack of correlation with previously reported risk factors. Am J Gastroenterol 96 (2001) 2778-2782
21. Sood A., Midha V., and Sood N. Reversible posterior leukoencephalopathy due to oral cyclosporine in severe ulcerative colitis. Indian J Gastroenterol 22 (2003) 233-234
22. Windebank A.J., Blexrud M.D., and de Groen P.C. Potential neurotoxicity of the solvent vehicle for cyclosporine. J Pharmacol Exp Ther 268 (1994) 1051-1056
23. Final report on the safety assessment of Ricinus Communis (Castor) Seed Oil, Hydrogenated Castor Oil, Glyceryl Ricinoleate, Glyceryl Ricinoleate SE, Ricinoleic Acid, Potassium Ricinoleate, Sodium Ricinoleate, Zinc Ricinoleate, Cetyl Ricinoleate, Ethyl Ricinoleate, Glycol Ricinoleate, Isopropyl Ricinoleate, Methyl Ricinoleate, and Octyldodecyl Ricinoleate. Int J Toxicol 26 Suppl 3 (2007) 31-77 No authors listed
24. Said G., Goasguen J., and Laverdant C. Neuropathy in long term treatment with metronidazole. Rev Neurol (Paris) 134 (1978) 515-521
25. Duffy L.F., Daum F., Fisher S.E., et al. Peripheral neuropathy in Crohn's disease patients treated with metronidazole. Gastroenterology 88 (1985) 681-684
26. Quallich L.G., Greenson J., Haftel H.M., et al. Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis. BMC Gastroenterol 1 (2001) 8
27. Watkinson G. Sulfasalazine: a review of 40 years' experience. Drugs 32 Suppl 1 (1986) 1-11
28. Logan E.C., Williamson L.M., and Ryrie D.R. Sulphasalazine associated pancytopenia may be caused by acute folate deficiency. Gut. 27 (1986) 868-872 10.1136/gut.27.7.868
29. Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353 (2005) 2462-2476
30. Ghosh S., Goldin E., Gordon F.H., et al. Natalizumab for active Crohn's disease. N Engl J Med 348 (2003) 24-32
31. 7 integrin. N Engl J Med 352 (2005) 2499-2507
32. Thomas Jr. C.W., Weinshenker B.G., and Sandborn W.J. Demyelination during anti-tumor necrosis alpha therapy with infliximab for Crohn's disease. Inflamm Bowel Dis 10 (2004) 28-31
33. Mejico L. Infliximab-associated retrobulbar optic neuritis. Arch Ophthalmol 122 (2004) 793-794
34. Colombel J.F., Loftus Jr. E.V., Tremaine W.J., et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology 126 (2004) 19-31
35. Freeman H.J., and Flak B. Demyelination-like symptoms in Crohn's disease after Infliximab therapy. Can J Gastroenterol 19 (2005) 313-316
36. Dubcenco E., Ottaway A., Chen D.L., et al. Neurological symptoms suggestive of demyelination in Crohn's disease after Infliximab therapy. Eur J Gastroentrol Hepatol 18 (2006) 565-566
37. Stübgen J.P. Tumor necrosis-alpha antagonists and neuropathy. Muscle Nerve 37 (2008) 281-292
38. Vadikolias K., Kouklakis G., Heliopoulos I., et al. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease. Eur J Gastroentrol Hepatol 19 (2007) 159-162
39. Van Assche G., Van Ranst M., Sciot R., et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353 (2005) 362-368
40. Berger J.R., and Koralnik I.J. Progressive multifocal leukoencephalopathy and natalizumab unforeseen consequences. N Eng J Med 353 (2005) 414-416
41. Gupta G., Gelfand J.M., and Lewis J.D. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129 (2005) 819-826
42. Bernstein C.N., Wajda A., and Blanchard J.F. The clustering of other chronic inflammatory bowel diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129 (2005) 827-836
43. Loftus Jr. E.V. Inflammatory bowel disease extending its reach. Editorial. Gastroenterology 129 (2005) 1117-1120
44. Heuer D.K., Gager W.E., and Reeser F.H. Ischemic optic neuropathy associated with Crohn's disease. J Clin Neuroophthalmol 2 (1982) 175-181
45. Froehlich F., Fried M., Gonvers J.J., et al. Association of Crohn's disease and Cogan's syndrome. Dig Dis Sci 39 (1994) 1134-1137
46. LIoyd D.A., Payton K.B., Guenther L., et al. Melkersson-Rosenthal syndrome and Crohn's disease: one disease or two? Report of a case and discussion of the literature. J Clin Gastroenterol 18 (1994) 213-217
47. Karajeh M.A., Hadjivassiliou M., Hurlstone P., et al. Neurological sequelae of Crohn's disease: opportunity to study common etiological pathways. J Gastroentrol Hepatol 19 (2004) 1093-1094
48. Sanders S.K., Kawasaki A., and Purvin V.A. Long-term prognosis in patients with vasculopathic sixth nerve palsy. Am J Ophthalmol 134 (2002) 81-84
49. Walker J.C., Selva D., Pietris G., et al. Optic disc swelling in Crohn's disease. Aust N Z J Ophthalmol 26 (1998) 329-332
50. van de Scheur M.R., van der Waal R.I., van Bodegraven A.A., et al. Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn's disease. J Clin Gastroenterol 34 (2002) 557-559
51. Romero Aroca P., Salvat Serra M., Perena Soriano F., et al. Anterior optic neuritis due to ulcerative colitis. Arch Soc Esp Ophthalmol 76 (2001) 189-191
52. Al-Malik H., and Green M.R. Cerebral venous thrombosis as a complication of Crohn's disease: a case report. J Pediatr Gastroenterol Nutr 32 (2001) 209-211
53. Samal S.C., Patra S., Reddy D.C., et al. Cerebral venous sinus thrombosis as presenting feature of Crohn's disease. Ind J Gastroenterol 23 (2004) 148-149
54. Maag J., and Prayson R.A. Intracranial sinus thrombosis in a patient with Crohn's disease and factor V Leiden mutation. Arch Pathol Lab Med 127 (2003) 1037-1039
55. Garcia-Moncó J.C., and Gómez Beldarrain M. Superior sagittal sinus thrombosis complicating Crohn's disease. Neurology 41 (1991) 1324-1325
56. Béchade D., Desramé J., Sallansonnet-Froment M., et al. Cerebral venous thrombosis in ulcerative colitis. Rev Med Interne 27 (2006) 958-961
57. Umit H., Asil T., Celik Y., et al. Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report. World J Gastroenterol 11 (2005) 5404-5407
58. Ryken T., and Menezes A. Inflammatory bowel disease and the craniocervical junction. Neurosurg Focus 6 (1999) e10
59. Moormann B., Herath H., Mann O., et al. Involvement of the peripheral nervous system in Crohn's disease. Nervenarzt 70 (1999) 1107-1111
60. Gobbelé R., Reith W., and Block F. Cerebral vasculitis as a concomitant neurological illness in Crohn's disease. Nervenarzt 71 (2000) 299-304
61. Ryan F.P., Timperley W.R., Preston F.E., et al. Cerebral involvement with disseminated intravascular coagulation in intestinal disease. J Clin Pathol 30 (1977) 551-555
62. Miehsler W., Reinisch W., Valic E., Osterode W., Tillinger W., Feichtenschlager T., Grisar J., Machold K., Scholz S., Vogelsang H., and Novacek G. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?. Gut 53 4 (2004) 542-548
63. Keene D.L., Matzinger M.A., Jacob P.J., et al. Cerebral vascular events associated with ulcerative colitis in children. Pediatr Neurol 24 (2001) 238-243
64. Mayeux R., and Fahn S. Strokes and ulcerative colitis. Neurology 28 (1978) 571-574
65. Schneiderman J.H., Sharpe J.A., and Sutton D.M. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol 5 4 (1979) 331-337
66. Lossos A., and Steiner I. Cerebrovascular disease in inflammatory bowel disease. In: Bogousslavsky J., and Kaplan L. (Eds). Uncommon causes of stroke (2001), Cambridge University Press, Cambridge 161-168
67. Hisada T., Miyamae Y., Mizuide M., Shibusawa N., Iida T., Masuo T., Okada S., Sagawa T., Ishizuka T., Kusano M., and Mori M. Acute thrombocytopenia associated with preexisting ulcerative colitis successfully treated with colectomy. Intern Med. 45 (2006) 87-91
68. Lam A., Borda I.T., Inwood M.J., et al. Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68 (1975) 245-251
69. Levine A., Lahav J., Zahavi I., et al. Activated protein C resistance in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 26 (1998) 172-174
70. Akobeng A.K., Miller V., and Thomas A.G. Epilepsy and Crohn's disease in children. J Pediatr Gastroenterol Nutr 26 (1998) 458-460
71. Paradis K., Bernstein M.L., and Adelson J.W. Thrombosis as a complication of inflammatory bowel disease in children: a report of four cases. J Pediatr Gastroenterol Nutr 4 (1985) 659-662
72. Ertem D., Ozguven E., Acar Y., et al. Thromboembolic complications in children with Crohn's disease. J Pediatr Gastroenterol Nutr 28 (1999) 540-541
73. Weber P., Husemann S., Vielhaber H., et al. Coagulation and fibrinolysis in children, adolescent and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 28 (1999) 418-422
74. Chamouard P., Grunebaum L., Wiesel M.L., et al. Prevalence and significance of anticardiolipin antibodies in Crohn's disease. Dig Dis Sci 39 (1994) 1501-1504
75. Souto J.C., Borell M., Fontcuberta J., et al. Antiphospholipid antibodies in inflammatory bowel disease. Dig Dis Sci 40 (1995) 1524-1525
76. Purrmann J., Arendt G., Cleveland S., et al. Association of Crohn's disease and multiple sclerosis. Is there a common background?. J Clin Gastroenterol 14 (1992) 43-46
77. Buccino G.P., Corrente G., and Visintini D. Crohn's disease and multiple sclerosis:a single case report. Ital J Neurol Sci 15 (1994) 303-306
78. Kitchin L.I., Knobler R.L., and Friedman L.S. Crohn's disease in a patient with multiple sclerosis. J Clin Gastroenterol 13 (1991) 331-334
79. Beaugerie L., Lamy P., Ganne N., et al. Morbid associations in Crohn's disease. Study of a series of 832 patients. Presse Med 26 (1997) 892-894
80. Skeen M.B. Neurologic manifestations of gastrointestinal disease. Neurol Clin 20 (2002) 195-225
81. Meadway J. Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis. Proc R Soc Med 67 (1974) 324-325
82. Johns D.R. Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol 86 (1991) 367-370
83. Martin R.W., and Shah A. Myasthenia Gravis coexistent with Crohn's disease. J Clin Gastroenterol 13 (1991) 112-113
84. Finnie I.A., Shields R., Sutton R., et al. Crohn's disease and myasthenia gravis:a possible role for thymectomy. Gut 35 (1994) 278-279
85. Foroozan R., and Sambursky R. Ocular myasthenia gravis and inflammatory bowel disease: a case report and literature review. Br J Ophthalmol 87 (2003) 1186-1187
86. Miller T.N. Myasthenia gravis, ulcerative colitis and lichen planus. Proc R Soc Med 64 (1971) 807-808
87. Gower-Rousseau C., Remaux D., Bellard M., et al. Remission of myasthenia gravis after proctocolectomy in a patient with ulcerative colitis. Am J Gastroenterol 88 (1993) 1136-1138
88. Tan R.S. Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo. Proc R Soc Med 67 (1974) 195-196
89. Papatestas A.E., Kim U., Genkins G., et al. The association of carcinoembryonic antigen and peripheral lymphocytes. Surgery 78 (1975) 343-348
90. Souadijian J.V., Enriquez P., Silverstein M.N., et al. The spectrum of disease associated with thymoma. Coincidence or syndrome?. Arch Intern Med 134 (1974) 374-379
91. Aiso S., Yoshida T., Watanabe M., et al. Characterization of thymus cells in hyperplastic thymuses in patients with myasthenia gravis and ulcerative colitis with monoclonal antibodies. J Clin Lab Immunol 13 (1984) 137-139
92. Menard D.B., Haddad H., Blain J.G., et al. Granulomatous myositis and myopathy associated with Crohn's disease. N Engl J Med 295 (1976) 818-819
93. Druschky A., Heckmann J., Engelhardt A., et al. Myositis-a rare complication of Crohn's disease. Fortschr Neurol Psychiatr 64 (1996) 422-424
94. Qureshi J.A., Staugaitis S.M., and Calabrese L.H. Neutrophilic myositis: an extra-intestinal manifestation of ulcerative colitis. J Clin Rheumatol 8 (2002) 85-88
95. Hall M.J., Thomas W.E., and Cooper B.T. Gastrocnemius myositis in a patient with inflammatory bowel disease. Digestion 32 (1985) 296-300
96. Gilliam III J.H., Chala V.R., Agudelo C.A., et al. Vasculitis involving muscle associated with Crohn's disease. Gastroenterology 81 (1981) 787-790
97. Lao J., Bostwick H.E., Berezin S., et al. Pyomyositis in a patient with Crohn's disease. J Pediatr Gastroenterol Nutr 20 (1995) 347-350
98. Seibold F., Klein R., and Jakob F. Polymyositis, alopecia universalis and primary sclerosing cholangitis in a patient with Crohn's disease. J Clin Gastroenterol 23 (1996) 121-124
99. Voigt E., Griga T., Tromm A., et al. Polymyositis of the skeletal muscles as an extraintesinal complication in quiescent ulcerative colitis. Int J Colorectal Dis 14 (1999) 304-307
100. Gelfenbeyn M., Goodkin R., and Kliot M. Sterile recurrent spinal epidural abscess in a patient with Crohn's disease: a case report. Surg Neurol 65 (2006) 178-184
101. Wallace J.R., and Luchi M. Crohn's disease complicated by meningitis and spinal epidural abscess. Clin Infect Dis 20 (1995) 1428-1429
102. Murai H., Tokunaga H., Kubo I., et al. Myeloradiculitis caused by cryptococcus neoformans infection in a patient with ulcerative colitis: a neuropathological study. J Neurol Sci 247 (2006) 236-238
103. Kraus J.A., Nahser H.C., and Berlit P. Lymphocytic encephalomyeloneuritis as a neurologic complication of ulcerative colitis. J Neurol Sci 141 (1996) 117-119
104. Geissler A., Andus T., Roth M., et al. Focal white matter lesions in brain of patients with inflammatory bowel disease. Lancet 345 (1995) 897-898
105. Kuczkowski J., Kozlowski J., and Narozny W. Acute autoimmune sensorineural hearing loss in pregnant women with Lesniowski-Crohn disease. Otolaryngol Pol 60 (2006) 583-585
106. Akbayir N., Calis A.B., Alkim C., et al. Sensorineural hearing loss in patients with inflammatory bowel disease:a subclinical extraintestinal manifestation. Dig Dis Sci 50 (2005) 1938-1945
107. Kumar B.N., Walsh R.M., Wilson P.S., et al. Sensorineural hearing loss and ulcerative colitis. J Laryngol Otol 111 (1997) 277-278
108. Herdman R.C., Hirari M., and Ramsden R.T. Autoimmune inner ear disease and ulcerative colitis. J Laryngol Otol 105 (1991) 330-331
109. Folwaczny C., Wiebecke B., and Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 94 (1999) 1551-1555 10.1111/j.1572-0241.1999.01143.x
110. Törkvist L., Thorlacius H., Sjöqvist U., Bohman L., Lapidus A., Flood L., Agren B., Raud J., and Löfberg R. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 13 (1999) 1323-1328 10.1046/j.1365-2036.1999.00599.x
111. Grip O., Svensson P.J., and Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 35 (2000) 619-623 10.1080/003655200750023589
112. Podolsky D.K. Inflammatory bowel disease (2). N Engl J Med 325 (1991) 1008-1016